Protara Therapeutics

1. IV Choline Chloride Ph3 interim4Q 2026IV Choline Chloride Ph3 interim, 4Q 2026, material
2. TARA-002 NMIBC Ph3 start4Q 2026TARA-002 NMIBC Ph3 start, 4Q 2026, notable
3. TARA-002 NMIBC enrollment done4Q 2026TARA-002 NMIBC enrollment done, 4Q 2026, notable
4. TARA-002 Lymphatic Malformations enrollment done4Q 2026TARA-002 Lymphatic Malformations enrollment done, 4Q 2026, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.